Literature DB >> 17681885

The anti-inflammatory activities of Staphylococcus aureus.

Triantafyllos Chavakis1, Klaus T Preissner, Mathias Herrmann.   

Abstract

Staphylococcus aureus is a versatile and harmful pathogen in both hospital- and community-associated infections that range from superficial to systemic infections. S. aureus engages a multitude of mechanisms to subvert the innate immune response of the host, including inhibition of complement activation and neutralization of anti-microbial peptides. In addition, inflammatory cell and phagocyte recruitment is an integral part of the innate defense to staphylococcal infection and comprises a well-coordinated multi-step cascade of adhesive events. Recent and rapidly growing experimental evidence indicates the existence of a machinery of anti-adhesive and anti-chemotactic moieties of S. aureus that allow the bacterium to interfere with specific adhesive steps of the homing mechanism of leukocytes. Understanding the functions of these S. aureus-derived anti-inflammatory agents could also provide the platform for designing new therapies in several inflammatory and autoimmune diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17681885     DOI: 10.1016/j.it.2007.07.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  33 in total

1.  NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs.

Authors:  James D Thacker; Brian J Balin; Denah M Appelt; Sihem Sassi-Gaha; Mitali Purohit; Richard F Rest; Carol M Artlett
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

2.  Allosteric inhibition of complement function by a staphylococcal immune evasion protein.

Authors:  Hui Chen; Daniel Ricklin; Michal Hammel; Brandon L Garcia; William J McWhorter; Georgia Sfyroera; You-Qiang Wu; Apostolia Tzekou; Sheng Li; Brian V Geisbrecht; Virgil L Woods; John D Lambris
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

Review 3.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

4.  Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d.

Authors:  Nurit Haspel; Daniel Ricklin; Brian V Geisbrecht; Lydia E Kavraki; John D Lambris
Journal:  Protein Sci       Date:  2008-08-07       Impact factor: 6.725

5.  Neutrophil recruitment: perivascular macrophages 'duke it out' with Staphylococcus aureus.

Authors:  Francis W Luscinskas
Journal:  Nat Immunol       Date:  2014-01       Impact factor: 25.606

Review 6.  Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.

Authors:  Brandon L Garcia; Kasra X Ramyar; Daniel Ricklin; John D Lambris; Brian V Geisbrecht
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  [Microbial stress of skin and wounds in clinical aspects and practice. Between search and destroy and monitor and relax].

Authors:  G Daeschlein; S Lutze; M Jünger
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

8.  Evaluation of capsular and acapsular strains of S. aureus in an experimental brain abscess model.

Authors:  Nilufer Esen; Gail Wagoner; Napoleon Philips
Journal:  J Neuroimmunol       Date:  2009-11-10       Impact factor: 3.478

9.  The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation.

Authors:  Masahiro Azuma; Ryoko Sawahata; Yuusuke Akao; Takashi Ebihara; Sayuri Yamazaki; Misako Matsumoto; Masahito Hashimoto; Koichi Fukase; Yukari Fujimoto; Tsukasa Seya
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

10.  A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.

Authors:  Daniel Ricklin; Apostolia Tzekou; Brandon L Garcia; Michal Hammel; William J McWhorter; Georgia Sfyroera; You-Qiang Wu; V Michael Holers; Andrew P Herbert; Paul N Barlow; Brian V Geisbrecht; John D Lambris
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.